Aspergillosis: Expanding spectrum of pulmonary disease

Clinical Pulmonary Medicine

Volumn 5, Issue 3, 1998, Pages 151-157

  Kane, Gregory C ^a,b   Salazar, Ana ^a   Israel, Harold L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b 805 College Building   (United States)

Author keywords

Allergic bronchopulmonary aspergillosis; Amphotericin B; Aspergillosis; Itraconazole; Mycetoma

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIFUNGAL ACTIVITY; ASPERGILLOSIS; ASPERGILLUS; BLEEDING; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERSENSITIVITY; LUNG DISEASE; MYCETOMA; PREVALENCE; REVIEW;

EID: 0031860821     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199805000-00002     Document Type: Review

References (50)

1. Groll A, Shah PM, Meutzel CH, Schnieder M. Changing pattern of invasive mycoses at autopsy. Interscience conference on antimicrobial agents and chemotherapy. Orlando, FL: American Society of Microbiology, October 1994. Abstract J109.
2. Bodey G, Bueltman B, Duguid W, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992;11:99-109.
3. Wheat JL. Fungal diseases of the lung. Orlando, FL: Greene and Stratton, 1986:43-68.
4. Katzenstein AL, Liebow AA, Friedman PJ. Bronchocentric granulomatosis, mucosal implication and other hypersensitivity reactions to fungi. Am Rev Respir Dis 1975;111: 497-537.
5. Greenberger PA. Allergic bronchopulmonary aspergillosis and mycoses. Clin Chest Med 1988;9:599-608.
6. Hinson KFW, Moor AJ, Plummer NS. Bronchopulmonary aspergillosis: a review and report of 8 new cases. Thorax 1952;7:317-33.
7. Slavin RG, Stanczyk DJ, Lonigro AJ, Brown CO. Allergic bronchopulmonary aspergillosis: a North American rarity. Am J Med 1969;47: 306-13.
8. Schwartz HJ, Greenberger PA. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologie criteria in patients at risk. J Lab Clin Med 1991;117:138-42.
9. Simmonds EJ, Littlewood JM, Evans EGV. Cystic fibrosis and allergic bronchopulmonary aspergillosis. Arch Dis Child 1990;65:507-11.
10. Riley DJ, Mackenzie JW, Uhlman WE, Edelman NH. Allergic bronchopulmonary aspergillosis. Evidence of limited tissue invasion. Am Rev Respir Dis 1975;111:232-6.
11. Patterson R, Greenberger PA, Lee TM, et al. Prolonged evaluation of patients with corticosteroid-dependent asthma stage of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1987;80:663-8.
12. Safirstein BH, D'Souza MF, Simon G, Tai EH, Pepys J. Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1973;108:450-9.
13. Denning DW, Van Wye JE, Leviston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991;100:813-9.
14. Mannes GP, van der Heide S, van Aalderen WM, Gerritsen J. Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis [letter]. Lancet 1993;341:492.
15. Israel HL, Lenchner GS, Atkinson GW. Sarcoidosis and aspergilloma - the role of surgery. Chest 1982;82:430-2.
16. Glimp RA, Bayer AS. Pulmonary aspergilloma. Diagnostic and therapeutic considerations. Arch Intern Med 1983;143:303-8.
17. Maguire CP, Hayes JP, Hayes M, Masteson J, FitzGerald MX. Three cases of aspergilloma in adult patients with cystic fibrosis. Thorax 1995;50:805-6.
18. Hsieh M-J, Shieh W-B, Chen K-S, Yu T-J, Kuo H-P, Tsai Y-H. Pulmonary actinomycosis appearing as a "ball in hole" on chest radiography and bronchoscopy. Thorax 1996;51: 221-2.
19. Eastridge CE, Young JM, Cook F, Gourley MD, Pate JW. Pulmonary aspergillosis. Ann Thorac Surg 1972;13:397-403.
20. Hargis JL, Bone RC, Stewart J, Rector N, Hiller FC. Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas. Am J Med 1980;68:389-94.
21. Jackson M, Flower CDR, Schneerson JM. Treatment of symptomatic pulmonary aspergillosis with intracavitary instillation of amphotericin B through an indwelling catheter. Thorax 1993;48:928-30.
22. Rumbak M, Kohler G, Eastridge C, Winer-Muram H, Gavant M. Topical treatment of line threatening haemoptysis from aspergillomas. Thorax 1996;51:253-5.
23. Cruccu V, Pedretti D, Confalonieri F. [A case of pulmonary aspergillosis effectively treated with itraconazole. Possible interaction of the antimycotic agent with hydroquinidine]. [in Italian]. Clin Ter 1995;146:383-9.
24. Tomee JF, van der Werf TS, Latge JP, Koeter GH, Dubois AE, Kaufman HF. Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma. Am J Respir Crit Care Med 1995;151:199-204.
25. Lebeau B, Pelloux H, Pinel C, et al. Itraconazole treatment of aspergillosis: a study of 16 patients. Mycoses 1994;37:171-9.
26. Denning DW. Aspergillus tracheobronchitis. Clin Infect Dis 1994;19:1176-7.
27. Denning DW. Commentary: unusual manifestations of aspergillosis. Thorax 1995;50:812-3.
28. Nicholson AG, Sim KM, Keogh BF, Corrin B. Pseudomembranous necrotising bronchial aspergillosis complicating chronic airways limitation. Thorax 1995;50:807-8.
29. Atkinson GW, Israel HL. 5-Fluorocytosine treatment of meningeal and pulmonary aspergillosis. Am J Med 1973;55:496-514.
30. Gefter WB, Weingard TR, Epstein DM, Ochs RH, Miller WT. "Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of Aspergillus infections of the lung. Radiology 1981;140:313-21.
31. Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) 1982;61:109-24.
32. Libshitz HI, Atkinson GW, Israel HL. Pleural thickening as a manifestation of Aspergillus superinfection. Am J Roentgenol Radium Ther Nucl Med 1974;120:883-6.
33. Caras WE, Pluss JL. Chronic necrotizing pulmonary aspergillosis. Pathologic outcome other itraconazole therapy. Mayo Clin Proc 1996;71:25-31.
34. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lurk EJ, Casseleth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100:345-51.
35. Gustafson TL, Shaffner W, Lavely GP, Stratton CW, Johnson HK, Hutcheson RH. Invasive aspergillosis in renal transplant recipients, correlation with steroid therapy. J Infect Dis 1983; 148:230-8.
36. Fraser PS. Pulmonary aspergillosis: pathologic and pathogenetic features. Pathol Annu 1993; 28:231-77.
37. Anderson K, Morris G, Kennedy H, et al. Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air. Thorax 1996;51: 256-61.
38. Case records of the Massachusetts General Hospital. Weekly dinicopathological exercises. Case 14-1996. A 66-year-old woman with toxic epidermal necrolysis and a fatal course. N Engl J Med 1996;334:1254-61.
39. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990;12:1147-201.
40. Westney GE, Kesten S, De Hoyos A, Chapparro C, Winton T, Maurer JR. Aspergillus infection in single and double lung transplant recipients. Transplantation 1996;61:915-9.
41. Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis. Am Rev Respir Dis 1991;144(3 Pt 1):552-6.
42. Larry H, Horak DA, Tegtmeiar BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992;86:243-8.
43. Kibbler CC, Milkins SR, Bhamra A, et al. Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients. Thorax 1988;43:108-12.
44. Denning DW, Fullanshee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immune deficiency syndrome. N Engl J Med 1991;324:654-62.
45. Lortholary O, Meyohas MC, Dupont B, et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Am J Med 1993;95:177-87.
46. Miller WT Jr, Sais GJ, Frank I, Gefter WB, Aroncik JM, Miller WT. Pulmonary aspergillosis in patients with AIDS. Clinical and radiographic correlations. Chest 1994;105:37-44.
47. Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med 1990;86:791-800.
48. Graybill JR. Lipid formulations for amphotericin B: does the emperor need new clothes? Ann Intern Med 1996;124:921-3.
49. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 1990;23(3 Pt 2):607-14.
50. van't Wout JW, Novakova I, Verhagen CA, Fibbe WE, de Pauw BE, van der Meer JW. Efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. J Infect 1991;22:45-52.